Phase 2 Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged 18 years or older.
- People whose CT scan shows multiple ground-glass nodules (small hazy spots) in the lung, with at least one nodule measuring between 0.5 cm and 3.0 cm across.
- People where at least one of these nodules has been confirmed as cancerous or pre-cancerous through a tissue or cell sample analysis.
- People with a life expectancy of at least 12 weeks.
- People whose lung function tests show results at or above 70% of the expected normal level for their age and size.
- People who have signed a consent form agreeing to take part in the trial.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are pregnant or currently breastfeeding.
- People who have had another active cancer diagnosed within the past 5 years.
- People with serious heart, liver, or kidney problems, such as severe heart failure or significantly abnormal liver or kidney test results (confirm with trial site for specific values).
- People with an uncontrolled serious infection or a condition that significantly weakens the immune system.
- People who have taken part in another interventional clinical trial within the 4 weeks before enrolling in this trial.
- People who are known to have an allergy or sensitivity to any ingredient in the study treatment (recombinant human p53 adenovirus injection).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86+020-83062807
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective Response Rate (ORR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.